600993 马应龙
已收盘 07-13 15:00:00
资讯
新帖
简况
每周股票复盘：马应龙（600993）两药品新入基药目录
证券之星 · 07-12 02:24
每周股票复盘：马应龙（600993）两药品新入基药目录
马应龙（600993）披露子公司获得药品注册证书公告，7月10日股价下跌2.31%
证券之星 · 07-10
马应龙（600993）披露子公司获得药品注册证书公告，7月10日股价下跌2.31%
马应龙最新公告：子公司盐酸氮䓬斯汀滴眼液获药品注册证书
证券之星 · 07-10
马应龙最新公告：子公司盐酸氮䓬斯汀滴眼液获药品注册证书
7月9日马应龙发生1笔大宗交易 成交金额532.8万元
证券之星 · 07-09
7月9日马应龙发生1笔大宗交易 成交金额532.8万元
马应龙（600993）披露公司药品新增进入《国家基本药物目录》公告，7月9日股价上涨2.28%
证券之星 · 07-09
马应龙（600993）披露公司药品新增进入《国家基本药物目录》公告，7月9日股价上涨2.28%
马应龙（600993）披露将参加湖北辖区上市公司2026年投资者集体接待日活动，7月02日股价上涨1.62%
证券之星 · 07-02
马应龙（600993）披露将参加湖北辖区上市公司2026年投资者集体接待日活动，7月02日股价上涨1.62%
当代年轻人的难言之隐，养活了“老字号”马应龙
蓝鲸财经 · 06-29
当代年轻人的难言之隐，养活了“老字号”马应龙
每周股票复盘：马应龙（600993）获聚乙二醇3350散药品注册证书
证券之星 · 06-28
每周股票复盘：马应龙（600993）获聚乙二醇3350散药品注册证书
马应龙（600993）披露获得聚乙二醇3350散药品注册证书公告，6月25日股价下跌3.13%
证券之星 · 06-25
马应龙（600993）披露获得聚乙二醇3350散药品注册证书公告，6月25日股价下跌3.13%
每周股票复盘：马应龙（600993）2025年年度股东会决议公告
证券之星 · 06-20
每周股票复盘：马应龙（600993）2025年年度股东会决议公告
马应龙（600993）披露2025年年度股东会决议公告，6月17日股价下跌1.76%
证券之星 · 06-17
马应龙（600993）披露2025年年度股东会决议公告，6月17日股价下跌1.76%
马应龙新注册《马应龙药业群聊AI智能管理系统V1.0》项目的软件著作权
证券之星 · 06-13
马应龙新注册《马应龙药业群聊AI智能管理系统V1.0》项目的软件著作权
每周股票复盘：马应龙（600993）将召开2025年年度股东会
证券之星 · 05-31
每周股票复盘：马应龙（600993）将召开2025年年度股东会
马应龙（600993）披露关于召开2025年年度股东会的通知，5月26日股价下跌0.25%
证券之星 · 05-26
马应龙（600993）披露关于召开2025年年度股东会的通知，5月26日股价下跌0.25%
马应龙（600993）披露子公司获得溴芬酸钠滴眼液药品注册证书，5月25日股价下跌0.87%
证券之星 · 05-25
马应龙（600993）披露子公司获得溴芬酸钠滴眼液药品注册证书，5月25日股价下跌0.87%
每周股票复盘：马应龙（600993）子公司获溴芬酸钠滴眼液注册证
证券之星 · 05-24
每周股票复盘：马应龙（600993）子公司获溴芬酸钠滴眼液注册证
马应龙(600993.SH)子公司溴芬酸钠滴眼液获得药品注册证书
智通财经 · 05-22
马应龙(600993.SH)子公司溴芬酸钠滴眼液获得药品注册证书
每周股票复盘：马应龙（600993）控股子公司终止转让医院股权
证券之星 · 05-10
每周股票复盘：马应龙（600993）控股子公司终止转让医院股权
马应龙最新公告：控股子公司终止转让北京医管79.81%股权
证券之星 · 05-08
马应龙最新公告：控股子公司终止转让北京医管79.81%股权
股市必读：马应龙年报 - 第四季度单季净利润同比增长14.01%
证券之星 · 04-27
股市必读：马应龙年报 - 第四季度单季净利润同比增长14.01%
加载更多
公司概况
公司名称：
马应龙药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2004-05-17
主营业务：
马应龙药业集团股份有限公司的主营业务是医药工业、医药商业和医疗服务。公司的主要产品是马应龙麝香痔疮膏、麝香痔疮栓、地奥司明片、痔炎消片、龙珠软膏、马应龙八宝眼膏。公司于2023年10月26日通过高新技术企业再次认定，获得编号为GR202342001690的高新技术企业证书，认定有效期为三年。
发行价格：
16.11
{"stockData":{"symbol":"600993","market":"SH","secType":"STK","nameCN":"马应龙","latestPrice":24.07,"timestamp":1783926001000,"preClose":23.25,"halted":0,"volume":10594547,"delay":0,"changeRate":0.0353,"floatShares":430000000,"shares":430999999,"eps":1.37,"marketStatus":"已收盘","change":0.82,"latestTime":"07-13 15:00:00","open":23.34,"high":24.43,"low":23.26,"amount":254000000,"amplitude":0.0503,"askPrice":24.08,"askSize":136,"bidPrice":24.07,"bidSize":149,"shortable":0,"etf":0,"ttmEps":1.37,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783992600000},"marketStatusCode":5,"adr":0,"adjPreClose":23.25,"symbolType":"stock","openAndCloseTimeList":[[1783906200000,1783913400000],[1783918800000,1783926000000]],"highLimit":25.58,"lowLimit":20.93,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":431053891,"isCdr":false,"pbRate":2.26,"roa":"--","peRate":17.569343,"roe":"4.73%","epsLYR":1.35,"committee":-0.231593,"marketValue":10375000000,"turnoverRate":0.0246,"status":0,"floatMarketCap":10357000000},"requestUrl":"/m/hq/s/600993","defaultTab":"news","newsList":[{"id":"2650549661","title":"每周股票复盘：马应龙（600993）两药品新入基药目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2650549661","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650549661?lang=zh_cn&edition=full","pubTime":"2026-07-12 02:24","pubTimestamp":1783794253,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，马应龙报收于23.25元，较上周的22.87元上涨1.66%。本周，马应龙7月9日盘中最高价报24.24元。交易信息汇总7月9日马应龙发生1笔大宗交易，成交金额532.8万元。公司公告汇总马应龙两个药品新增纳入《国家基本药物目录》，分别为马应龙八宝眼膏和托法替布片（处方药），适用于眼部炎症及类风湿关节炎等疾病，有利于未来市场拓展，但对当前经营业绩暂无重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000753.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0239","BK0188","BK0028","600993"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650352741","title":"马应龙（600993）披露子公司获得药品注册证书公告，7月10日股价下跌2.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650352741","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650352741?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:27","pubTimestamp":1783693635,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，马应龙报收于23.25元，较前一交易日下跌2.31%，最新总市值为100.22亿元。近日，马应龙药业集团股份有限公司披露公告，其子公司江西马应龙美康药业有限公司收到国家药品监督管理局核准签发的盐酸氮斯汀滴眼液《药品注册证书》，注册分类为化学药品4类，非处方药，上市许可持有人为江西马应龙美康药业有限公司，生产企业为浙江尖峰药业有限公司。截至目前，公司对该药品累计研发投入766.21万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000044593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600993","BK0096","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650837401","title":"马应龙最新公告：子公司盐酸氮䓬斯汀滴眼液获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2650837401","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650837401?lang=zh_cn&edition=full","pubTime":"2026-07-10 16:38","pubTimestamp":1783672687,"startTime":"0","endTime":"0","summary":"马应龙(600993.SH)公告称，公司子公司江西马应龙美康药业收到国家药监局核准签发的盐酸氮䓬斯汀滴眼液《药品注册证书》。该药品适用于治疗过敏性结膜炎引起的眼痒症状，为化学药品4类非处方药。2025年该药品国内市场销售额达1.54亿元，公司累计研发投入766.21万元。此次获批有助于丰富公司眼科产品线，但药品生产销售受行业政策及市场竞争影响存在不确定性。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000029351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0028","BK0239","600993","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650407549","title":"7月9日马应龙发生1笔大宗交易 成交金额532.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650407549","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650407549?lang=zh_cn&edition=full","pubTime":"2026-07-09 17:24","pubTimestamp":1783589089,"startTime":"0","endTime":"0","summary":"证券之星消息，7月9日马应龙发生大宗交易，交易数据如下：大宗交易成交价格22.2元，相对当日收盘价折价6.72%，成交24万股，成交金额532.8万元，买方营业部为招商证券股份有限公司沈阳兴工街证券营业部，卖方营业部为中泰证券股份有限公司杭州湖墅南路证券营业部。近三个月该股共发生1笔大宗交易，合计成交2400.0手，折价成交1笔。截至2026年7月9日收盘，马应龙报收于23.8元，上涨2.28%，换手率2.26%，成交量9.74万手，成交额2.32亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900030812.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600993","BK0096","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650409489","title":"马应龙（600993）披露公司药品新增进入《国家基本药物目录》公告，7月9日股价上涨2.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650409489","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650409489?lang=zh_cn&edition=full","pubTime":"2026-07-09 17:18","pubTimestamp":1783588683,"startTime":"0","endTime":"0","summary":"截至2026年7月9日收盘，马应龙报收于23.8元，较前一交易日上涨2.28%，最新总市值为102.59亿元。该股当日开盘23.21元，最高24.24元，最低22.98元，成交额达2.32亿元，换手率为2.26%。近日，马应龙药业集团股份有限公司发布关于公司药品新增进入《国家基本药物目录》的公告。公告显示，2026年7月9日，国家卫生健康委员会等部门发布《国家基本药物目录》，马应龙有两个药品新增纳入目录，分别为马应龙八宝眼膏和托法替布片，无药品退出。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900030270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600993","BK0028","BK0188","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648468622","title":"马应龙（600993）披露将参加湖北辖区上市公司2026年投资者集体接待日活动，7月02日股价上涨1.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648468622","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648468622?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:57","pubTimestamp":1783004232,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘，马应龙报收于22.6元，较前一交易日上涨1.62%，最新总市值为97.42亿元。近日，马应龙药业集团股份有限公司发布《关于参加湖北辖区上市公司2026年投资者集体接待日活动的公告》。公告显示，公司将于2026年7月9日14:00-17:00通过网络远程方式参加由湖北证监局指导，湖北省上市公司协会与深圳市全景网络有限公司联合举办的“湖北辖区上市公司2026年投资者集体接待日活动”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200042621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0096","BK0239","BK0028","600993"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647327203","title":"当代年轻人的难言之隐，养活了“老字号”马应龙","url":"https://stock-news.laohu8.com/highlight/detail?id=2647327203","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647327203?lang=zh_cn&edition=full","pubTime":"2026-06-29 17:22","pubTimestamp":1782724955,"startTime":"0","endTime":"0","summary":"而这条赛道里最具代表性的企业，是马应龙。精准吃透年轻人从预防到治疗的全链条需求后，马应龙搭建起分层清晰的产品矩阵。其中，仅麝香痔疮膏一年销量就近2亿支，牢牢守住肛肠药品成熟市场，也在消费者心中形成“肛周不适优先选马应龙”的固有认知。他们不好意思说出口的小毛病，撑起了马应龙近40亿元的年营收。依托稳定的大众刚需，马应龙沉淀出充足且可持续的现金流。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1782291655084784604","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0239","BK0028","BK0188","BK0096","600993"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646315319","title":"每周股票复盘：马应龙（600993）获聚乙二醇3350散药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2646315319","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646315319?lang=zh_cn&edition=full","pubTime":"2026-06-28 03:10","pubTimestamp":1782587421,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，马应龙报收于21.55元，较上周的22.58元下跌4.56%。本周，马应龙6月24日盘中最高价报23.48元。本周关注点公司公告汇总：马应龙获聚乙二醇3350散药品注册证书，用于缓解偶发性便秘。公司公告汇总马应龙药业集团股份有限公司收到国家药品监督管理局核准签发的聚乙二醇3350散《药品注册证书》，药品注册分类为化学药品3类，上市许可持有人和生产企业均为本公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0188","600993","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646809016","title":"马应龙（600993）披露获得聚乙二醇3350散药品注册证书公告，6月25日股价下跌3.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646809016","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646809016?lang=zh_cn&edition=full","pubTime":"2026-06-25 22:47","pubTimestamp":1782398831,"startTime":"0","endTime":"0","summary":"截至2026年6月25日收盘，马应龙报收于21.99元，较前一交易日下跌3.13%，最新总市值为94.79亿元。近日，马应龙药业集团股份有限公司披露《关于获得药品注册证书的公告》。公告显示，公司收到国家药品监督管理局核准签发的聚乙二醇3350散《药品注册证书》，药品注册分类为化学药品3类，上市许可持有人和生产企业均为本公司。该药品用于缓解偶发性便秘，截至目前公司累计研发投入238.62万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500044524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600993","BK0188","BK0239","BK0096","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644066631","title":"每周股票复盘：马应龙（600993）2025年年度股东会决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2644066631","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644066631?lang=zh_cn&edition=full","pubTime":"2026-06-20 03:43","pubTimestamp":1781898189,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，马应龙报收于22.58元，较上周的23.83元下跌5.25%。本周，马应龙6月15日盘中最高价报23.87元。本周关注点公司公告汇总：马应龙2025年年度股东会审议通过利润分配方案、年度报告等议案，表决结果合法有效。公司公告汇总马应龙药业集团股份有限公司于2026年6月17日在武汉召开2025年年度股东会，会议由董事会召集，董事长陈平主持，采用现场与网络投票相结合的方式进行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000002173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0096","600993","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644744076","title":"马应龙（600993）披露2025年年度股东会决议公告，6月17日股价下跌1.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644744076","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644744076?lang=zh_cn&edition=full","pubTime":"2026-06-17 22:33","pubTimestamp":1781706797,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘，马应龙报收于22.86元，较前一交易日下跌1.76%，最新总市值为98.54亿元。该股当日开盘23.26元，最高23.3元，最低22.83元，成交额达8985.25万元，换手率为0.91%。近日，马应龙药业集团股份有限公司发布《2025年年度股东会决议公告》。出席会议股东共495人，代表有表决权股份总数的47.9552%。所有议案均获有效通过，无否决议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700042317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0239","600993","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643297584","title":"马应龙新注册《马应龙药业群聊AI智能管理系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2643297584","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643297584?lang=zh_cn&edition=full","pubTime":"2026-06-13 02:28","pubTimestamp":1781288894,"startTime":"0","endTime":"0","summary":"证券之星消息，近日马应龙（600993）新注册了《马应龙药业群聊AI智能管理系统V1.0》项目的软件著作权。今年以来马应龙新注册软件著作权3个。结合公司2025年年报财务数据，2025年公司在研发方面投入了7811.46万元，同比增17.13%。通过天眼查大数据分析，马应龙药业集团股份有限公司共对外投资了31家企业，参与招投标项目15992次；财产线索方面有商标信息750条，专利信息229条，著作权信息63条；此外企业还拥有行政许可435个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061300000885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0096","159819","600993","BK0239","159180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639360469","title":"每周股票复盘：马应龙（600993）将召开2025年年度股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2639360469","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639360469?lang=zh_cn&edition=full","pubTime":"2026-05-31 03:11","pubTimestamp":1780168269,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，马应龙报收于24.19元，较上周的24.11元上涨0.33%。本周，马应龙5月29日盘中最高价报24.35元。5月29日盘中最低价报23.09元，股价触及近一年最低点。马应龙当前最新总市值104.27亿元，在中药板块市值排名19/66，在两市A股市值排名1907/5207。股权登记日为2026年6月10日，股东可于6月11日通过邮件、信函或扫码方式登记参会。现场会议于6月17日14时30分在武汉召开。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100000877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600993","BK0188","BK0239","BK0096","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638543109","title":"马应龙（600993）披露关于召开2025年年度股东会的通知，5月26日股价下跌0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638543109","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638543109?lang=zh_cn&edition=full","pubTime":"2026-05-26 22:35","pubTimestamp":1779806119,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，马应龙报收于23.84元，较前一交易日下跌0.25%，最新总市值为102.76亿元。该股当日开盘23.93元，最高24.12元，最低23.78元，成交额达7815.96万元，换手率为0.76%。近日，马应龙药业集团股份有限公司披露《关于召开2025年年度股东会的通知》。公告显示，公司将于2026年6月17日召开2025年年度股东会，会议采取现场与网络投票相结合方式，网络投票通过上海证券交易所系统进行。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600041349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600993","BK0096","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638953147","title":"马应龙（600993）披露子公司获得溴芬酸钠滴眼液药品注册证书，5月25日股价下跌0.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638953147","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638953147?lang=zh_cn&edition=full","pubTime":"2026-05-25 17:48","pubTimestamp":1779702500,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘，马应龙报收于23.9元，较前一交易日下跌0.87%，最新总市值为103.02亿元。近日，马应龙药业集团股份有限公司发布公告称，其子公司江西马应龙美康药业有限公司收到国家药品监督管理局核准签发的溴芬酸钠滴眼液《药品注册证书》，药品注册标准编号为YBH12292026，批准文号为国药准字H20264422，有效期至2031年05月18日。该药品用于外眼部和前眼部炎症性疾病的对症治疗，目前国内已有17家企业获得该药品注册证书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500025241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600993","BK0188","BK0096","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637375893","title":"每周股票复盘：马应龙（600993）子公司获溴芬酸钠滴眼液注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2637375893","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637375893?lang=zh_cn&edition=full","pubTime":"2026-05-24 03:17","pubTimestamp":1779563830,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，马应龙报收于24.11元，较上周的25.52元下跌5.53%。本周，马应龙5月18日盘中最高价报25.5元。本周关注点公司公告汇总：子公司获溴芬酸钠滴眼液《药品注册证书》公告汇总马应龙药业集团股份有限公司子公司江西马应龙美康药业有限公司收到国家药品监督管理局核准签发的溴芬酸钠滴眼液《药品注册证书》，药品注册标准编号为YBH12292026，批准文号为国药准字H20264422，有效期至2031年05月18日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400000923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","600993","BK0239","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637915563","title":"马应龙(600993.SH)子公司溴芬酸钠滴眼液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2637915563","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637915563?lang=zh_cn&edition=full","pubTime":"2026-05-22 15:44","pubTimestamp":1779435896,"startTime":"0","endTime":"0","summary":"智通财经APP讯，马应龙(600993.SH)发布公告，近日，公司子公司江西马应龙美康药业有限公司(简称“马应龙美康”)收到国家药品监督管理局核准签发的溴芬酸钠滴眼液《药品注册证书》。据悉，溴芬酸钠滴眼液用于外眼部和前眼部的炎症性疾病的对症治疗[结膜炎、巩膜炎、术后炎症]。溴芬酸钠滴眼液于2000年首次在日本批准上市，2009年中国国家药品监督管理局批准原研进口上市。根据药智网数据，除马应龙美康外，目前国内有17家企业获得该药品的注册证书。根据药智网数据，2025年溴芬酸钠滴眼液国内市场销售额达1.28亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445008.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"马应龙(600993.SH)子公司溴芬酸钠滴眼液获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0096","BK0239","BK0188","600993","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634343414","title":"每周股票复盘：马应龙（600993）控股子公司终止转让医院股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2634343414","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634343414?lang=zh_cn&edition=full","pubTime":"2026-05-10 02:16","pubTimestamp":1778350572,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，马应龙报收于25.22元，较上周的26.03元下跌3.11%。本周，马应龙5月6日盘中最高价报26.18元。本周关注点公司公告汇总：马应龙控股子公司终止转让北京马应龙长青医院79.8144%股权，因受让方未支付履约保证金导致交易解除。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000000780.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","600993","BK0096","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633435694","title":"马应龙最新公告：控股子公司终止转让北京医管79.81%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2633435694","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633435694?lang=zh_cn&edition=full","pubTime":"2026-05-08 16:32","pubTimestamp":1778229164,"startTime":"0","endTime":"0","summary":"马应龙(600993.SH)公告称，公司控股子公司马应龙医管原拟将持有的北京医管79.81%股权转让给卓准技术，交易价格为1.04亿元。因受让方未按合同约定支付履约保证金，经催告后仍未足额支付，合同解除，本次交易终止。该事项不会对公司生产经营及财务状况造成重大不利影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800028756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0096","600993","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630310433","title":"股市必读：马应龙年报 - 第四季度单季净利润同比增长14.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630310433","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630310433?lang=zh_cn&edition=full","pubTime":"2026-04-27 06:39","pubTimestamp":1777243148,"startTime":"0","endTime":"0","summary":"2025年第四季度单季主营收入10.29亿元，同比增长9.95%；单季归母净利润8048.17万元，同比增长14.01%；单季扣非净利润9560.05万元，同比增长54.48%。公司公告汇总马应龙2025年年度报告摘要2025年公司实现营业收入3,866,608,233.15元，同比增长3.72%；归母净利润581,492,372.69元，同比增长10.11%；扣非后归母净利润563,726,172.23元，同比增长10.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700006732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600993"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783976564026,"stockEarnings":[{"period":"1week","weight":0.0397},{"period":"1month","weight":0.0101},{"period":"3month","weight":-0.0433},{"period":"6month","weight":-0.159},{"period":"1year","weight":-0.1119},{"period":"ytd","weight":-0.1404}],"compareEarnings":[{"period":"1week","weight":-0.0315},{"period":"1month","weight":-0.0292},{"period":"3month","weight":-0.028},{"period":"6month","weight":-0.0515},{"period":"1year","weight":0.115},{"period":"ytd","weight":-0.0139}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"马应龙药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"41404人(较上一季度增加28.17%)","perCapita":"10392股","listingDate":"2004-05-17","address":"湖北省武汉市洪山区武昌南湖周家湾100号","registeredCapital":"43105万元","survey":" 马应龙药业集团股份有限公司的主营业务是医药工业、医药商业和医疗服务。公司的主要产品是马应龙麝香痔疮膏、麝香痔疮栓、地奥司明片、痔炎消片、龙珠软膏、马应龙八宝眼膏。公司于2023年10月26日通过高新技术企业再次认定，获得编号为GR202342001690的高新技术企业证书，认定有效期为三年。","listedPrice":16.11},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"马应龙(600993)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供马应龙(600993)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"马应龙,600993,马应龙股票,马应龙股票老虎,马应龙股票老虎国际,马应龙行情,马应龙股票行情,马应龙股价,马应龙股市,马应龙股票价格,马应龙股票交易,马应龙股票购买,马应龙股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"马应龙(600993)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供马应龙(600993)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}